BC

Benecchi Christopher

US·SEC (Form 4)

Sage Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the complete record of transactions filed by Benecchi Christopher. Insider active across 1 company, notably Sage Therapeutics, Inc.. Aggregated, 7 disclosures have been published. History available since 3 February 2023. The latest transaction was disclosed on 10 April 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.

Declarations7 total

◆

Benecchi Christopher

Chief Operating OfficerExecutives10 Apr 2025Sage Therapeutics, Inc.

11SEC ↗

3,255 shares0Common StockSEC:0001562180-25-003114:0

●

Benecchi Christopher

Chief Operating OfficerExecutives13 Feb 2025Sage Therapeutics, Inc.

$5,90219SEC ↗

822 shares@ US$7.18100.0% of flowCommon StockSEC:0001562180-25-001202:0

◆